Adrian Wiestner

Also affiliated with National Heart Lung and Blood Institute, National Institutes of Health Clinical Center

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 40 papers. Top paper: “Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines”.

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Blood(2020)10.1182/blood.2020008758

N/A

7.9DataRank · unranked

141 citations

Mir A. Ali, Jeffrey I. Cohen, Xin Tian, Susan Soto, Inhye E. Ahn +9 more

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Blood(2020)10.1182/blood.2019003715

N/A

3.3DataRank · unranked

106 citations

Pia Nierman, Ellen K. Kendall, Jean Cheung, Michael Gulrajani, Sarah E. M. Herman +16 more

Long‐term efficacy of first‐line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials

British Journal of Haematology(2021)10.1111/bjh.17984

N/A

2.2DataRank · unranked

64 citations

Tait D. Shanafelt, Adrian Wiestner, Carol Moreno, Susan O’Brien, Jianling Li +4 more

Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3505

N/A

1.7DataRank · unranked

31 citations

Jean Cheung, Michael Gulrajani, Erika M. Gaglione, Pia Nierman, Ahmed Hamdy +8 more

Clinical Outcomes in Patients with Multi-Hit TP53 Chronic Lymphocytic Leukemia Treated with Ibrutinib

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4890

N/A

1.5DataRank · unranked

40 citations

Kathrine Aarup, Mathias H. Torp, Michael Asger Andersen, Christina W. Yde, Xin Tian +4 more

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006397

N/A

1.3DataRank · unranked

44 citations

Christopher Melani, Kieron Dunleavy, Stefania Pittaluga, Nakhle S. Saba, Liza Lindenberg +11 more

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

Blood Advances(2022)10.1182/bloodadvances.2021006941

N/A

1.2DataRank · unranked

50 citations

Yun-Ching Chen, Aina Zurita Martinez, Maria João Baptista, Stefania Pittaluga, Delong Liu +10 more

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3217

N/A

0.782DataRank · unranked

21 citations

Jonathan Chen, Erika M. Gaglione, Chingiz Underbayev, Pamela L. Tuma, Xin Tian +12 more

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004850

N/A

0.474DataRank · unranked

10 citations

Maissa Mhibik, Junpeng Qi, Haiyong Peng, Chang Jing, Erika M. Gaglione +9 more

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379

N/A

0.286DataRank · unranked

4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

A phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia

American Journal of Hematology(2020)10.1002/ajh.25968

N/A

0DataRank · unranked

5 citations

Xin Tian, Shakuntala Rampertaap, Rui Mu, Susan Soto, Jeanine Superata +12 more

Reconstitution of humoral immunity and decreased risk of infections in patients with chronic lymphocytic leukemia treated with Bruton tyrosine kinase inhibitors

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1772477

N/A

0DataRank · unranked

27 citations

Clare Sun, Sanjal H. Desai, Inhye E. Ahn, Xin Tian, Pia Nierman +6 more

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0063

N/A

0DataRank · unranked

61 citations

James D. Phelan, James Q. Wang, Dawei Huang, George W. Wright, Monica Kasbekar +26 more

Genomic evolution of ibrutinib‐resistant clones in Waldenström macroglobulinaemia

British Journal of Haematology(2020)10.1111/bjh.16463

N/A

0DataRank · unranked

36 citations

Gloria Chan, Lian Xu, Nickolas Tsakmaklis, Amanda Kofides, Maria Demos +10 more

MARCKS affects cell motility and response to BTK inhibitors in CLL

Blood(2021)10.1182/blood.2020009165

N/A

0DataRank · unranked

25 citations

Valeska Berg, Clarissa Dickhut, Clare Sun, Olaf Merkel, Johannes Bloehdorn +22 more

Siglec-6 is a target for chimeric antigen receptor T-cell treatment of chronic lymphocytic leukemia

Leukemia(2021)10.1038/s41375-021-01188-3

N/A

0DataRank · unranked

24 citations

Jeong Heon Yoon, Matthew G. Cyr, Samantha Simon, Elisaveta Voynova, Christoph Rader +5 more

CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.2002317

N/A

0DataRank · unranked

12 citations

Alba Navarro, Delong Liu, Sarah E. M. Herman, Shih‐Sung Chuang, Irma Slavutsky +9 more

Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4894

N/A

0DataRank · unranked

12 citations

Sivasubramanian Baskar, Erika M. Gaglione, Keyvan Keyvanfar, Inhye E. Ahn, Adrian Wiestner +2 more

SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-5039

N/A

0DataRank · unranked

10 citations

Stephanie Christie, Violetta V. Leshchenko, Rinku Jain, Abhijeet Kapoor, Paola Bisignano +13 more

Can Immunocompetence Be Restored in Chronic Lymphocytic Leukemia?

Hematology/Oncology Clinics of North America(2021)10.1016/j.hoc.2021.03.010

N/A

0DataRank · unranked

7 citations

Adrian Wiestner, Clare Sun

Expression of the muscle-associated gene MYF6 in hairy cell leukemia

PLoS ONE(2020)10.1371/journal.pone.0227586

N/A

0DataRank · unranked

8 citations

Hong Zhou, Mark Sokolsky, Daniel Gorelik, Katherine Potocka, Sarah Davies +13 more

Validating genomic tools for precision medicine in chronic lymphocytic leukemia: ERIC leads the way

Haematologica(2021)10.3324/haematol.2020.270652

N/A

0DataRank · unranked

1 citations

Adrian Wiestner

Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1894641

N/A

0DataRank · unranked

0 citations

Neil Basumallik, Robert Matulonis, Drake Scott, Dalia Salem, Gregory A. Jasper +6 more

Molecular map of chronic lymphocytic leukemia and its impact on outcome

Nature Genetics(2022)10.1038/s41588-022-01140-w

N/A

0DataRank · unranked

150 citations

Ziao Lin, Cynthia K. Hahn, Ferran Nadeu, Martí Duran‐Ferrer, Kristen E. Stevenson +34 more

Concurrent chronic lymphocytic leukemia/small lymphocytic lymphoma and hairy cell leukemia: clinical, pathologic and molecular features

Leukemia & lymphoma/Leukemia and lymphoma(2020)10.1080/10428194.2020.1797007

N/A

0DataRank · unranked

11 citations

Ivo M.B. Francischetti, Hao‐Wei Wang, Inhye E. Ahn, Weixin Wang, Mark Raffeld +4 more

Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1β–mediated colitis

Journal of Clinical Investigation(2020)10.1172/jci128322

N/A

0DataRank · unranked

106 citations

Atsushi Kitani, Eitaro Hiejima, Kim Montgomery-Recht, Wenchang Zhou, Ivan J. Fuss +3 more

Ibrutinib for Chronic Lymphocytic Leukemia with TP53 Alterations

New England Journal of Medicine(2020)10.1056/nejmc2005943

N/A

0DataRank · unranked

115 citations

Xin Tian, Adrian Wiestner, Inhye E. Ahn

Splenic Size and Volume Measurements in Patients with Chronic Lymphocytic Leukemia

Academic Radiology(2022)10.1016/j.acra.2022.06.013

N/A

0DataRank · unranked

6 citations

Li‐Yueh Hsu, Clare Sun, Pia Nierman, Adrian Wiestner, Elizabeth C. Jones +2 more

Enhanced Costimulatory Signaling Improves CAR T-cell Effector Responses in CLL

Cancer Research Communications(2022)10.1158/2767-9764.crc-22-0200

N/A

0DataRank · unranked

13 citations

In-Young Jung, Ziran Zhao, Kimberly Apodaca, Weimin Kong, Stefan Lundh +6 more

Cardiac toxicity in a pilot study of duvelisib and ibrutinib combination therapy for chronic lymphocytic leukaemia

British Journal of Haematology(2022)10.1111/bjh.18558

N/A

0DataRank · unranked

2 citations

Douglas R. Rosing, Mark C. Haigney, Cody J. Peer, William D. Figg, Adrian Wiestner +2 more

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Blood Advances(2023)10.1182/bloodadvances.2022009517

N/A

0DataRank · unranked

40 citations

Erika M. Gaglione, David Eik, John H. Herrick, J. Le, Inhye E. Ahn +11 more

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

0DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more

B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3887

N/A

0DataRank · unranked

17 citations

Paolo Ghia, John C. Byrd, Inhye E. Ahn, Carol Moreno, Susan O’Brien +8 more

Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application

Haematologica(2023)10.3324/haematol.2023.283178

N/A

0DataRank · unranked

1 citations

Terri Rasmussen, Lorena Fontán, Min Xia, Ari Melnick, Adrian Wiestner +7 more

Data from SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma

(2023)10.1158/1078-0432.c.6530477

N/A

0DataRank · unranked

0 citations

Stephanie Christie, Violetta V. Leshchenko, Rinku Jain, Abhijeet Kapoor, Paola Bisignano +13 more

Data from SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma

(2023)10.1158/1078-0432.c.6530477.v1

N/A

0DataRank · unranked

0 citations

Stephanie Christie, Violetta V. Leshchenko, Rinku Jain, Abhijeet Kapoor, Paola Bisignano +13 more

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

Leukemia(2025)10.1038/s41375-025-02662-y

N/A

0DataRank · unranked

18 citations

Thomas Chatzikonstantinou, Marina Gerousi, Richard Rosenquist, Gianluca Gaïdano, Šárka Pospı́šilová +12 more

Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy

Leukemia & lymphoma/Leukemia and lymphoma(2025)10.1080/10428194.2025.2466101

N/A

0DataRank · unranked

5 citations

Adrian Wiestner, Clare Sun, Christine Gruessner

Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data

Briefings in Bioinformatics(2025)10.1093/bib/bbaf516

N/A

0DataRank · unranked

3 citations

Jean-Baptiste Alberge, Tina Keshavarzian, Junko Tsuji, Johan E. Gustafsson, Mahshid Rahmat +13 more

Sudden death and asymptomatic arrhythmia in chronic lymphocytic leukemia patients treated with ibrutinib

Heart Rhythm(2025)10.1016/j.hrthm.2025.10.014

N/A

0DataRank · unranked

0 citations

Andy Itsara, Mark C. Haigney, Douglas R. Rosing, Inhye E. Ahn, Cody Peer +7 more